This webinar featured:

• Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients with Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-Based Target Trial Emulation
• Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis.